Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Avalo Therapeutics, Inc. | 118,321 | reported | 28 May 2026 | tx 30+674,905−275,823 |
| Cullinan Therapeutics, Inc. | 79,456 | reported | 07 Aug 2025 | tx 1+79,456 |
| DICE Therapeutics, Inc. | 0 | reported | 09 Aug 2023 | tx 2+42,500−42,500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 28 May 2026 | EXERCISE | Avalo Therapeutics, Inc. | 679 | 8.04 USD | 10b5-1 |
| 28 May 2026 | SALE | Avalo Therapeutics, Inc. | 679 | 16.00 USD | 10b5-1 |
| 28 May 2026 | EXERCISE | Avalo Therapeutics, Inc. | 679 | 0.00 USD | 10b5-1deriv |
| 21 May 2026 | GRANT_AWARD | Avalo Therapeutics, Inc. | 43,500 | 0.00 USD | |
| 15 May 2026 | EXERCISE | Avalo Therapeutics, Inc. | 3,000 | 12.65 USD | 10b5-1 |
| 15 May 2026 | SALE | Avalo Therapeutics, Inc. | 3,000 | 18.76 USD | 10b5-1 |
| 15 May 2026 | EXERCISE | Avalo Therapeutics, Inc. | 3,000 | 0.00 USD | 10b5-1deriv |
| 05 May 2026 | EXERCISE | Avalo Therapeutics, Inc. | 1,000 | 12.65 USD | 10b5-1 |
| 05 May 2026 | EXERCISE | Avalo Therapeutics, Inc. | 679 | 8.04 USD | 10b5-1 |
| 05 May 2026 | SALE | Avalo Therapeutics, Inc. | 1,679 | 16.00 USD | 10b5-1 |
| 06 May 2026 | EXERCISE | Avalo Therapeutics, Inc. | 77,905 | 12.65 USD | 10b5-1 |
| 06 May 2026 | EXERCISE | Avalo Therapeutics, Inc. | 28,650 | 8.04 USD | 10b5-1 |
| 06 May 2026 | SALE | Avalo Therapeutics, Inc. | 27,538 | 18.03 USD | 10b5-1 |
| 06 May 2026 | SALE | Avalo Therapeutics, Inc. | 5,000 | 19.65 USD | 10b5-1 |
| 06 May 2026 | SALE | Avalo Therapeutics, Inc. | 44,944 | 21.20 USD | 10b5-1 |
| 06 May 2026 | SALE | Avalo Therapeutics, Inc. | 19,015 | 22.41 USD | 10b5-1 |
| 06 May 2026 | SALE | Avalo Therapeutics, Inc. | 10,058 | 22.88 USD | 10b5-1 |
| 05 May 2026 | EXERCISE | Avalo Therapeutics, Inc. | 1,000 | 0.00 USD | 10b5-1deriv |
| 05 May 2026 | EXERCISE | Avalo Therapeutics, Inc. | 679 | 0.00 USD | 10b5-1deriv |
| 06 May 2026 | EXERCISE | Avalo Therapeutics, Inc. | 77,905 | 0.00 USD | 10b5-1deriv |
| 06 May 2026 | EXERCISE | Avalo Therapeutics, Inc. | 28,650 | 0.00 USD | 10b5-1deriv |
| 16 Mar 2026 | EXERCISE | Avalo Therapeutics, Inc. | 19,500 | 12.65 USD | |
| 16 Mar 2026 | EXERCISE | Avalo Therapeutics, Inc. | 5,992 | 8.04 USD | |
| 16 Mar 2026 | SALE | Avalo Therapeutics, Inc. | 25,492 | 16.15 USD | |
| 16 Mar 2026 | EXERCISE | Avalo Therapeutics, Inc. | 19,500 | 0.00 USD | deriv |